Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorbin and SH3 domain-containing protein 2 (SORBS2) is an adaptor and RNA-binding protein characterized by an N-terminal sorbin homology (SoHo) domain and three C-terminal SH3 domains. SORBS2 is highly enriched in cardiac and skeletal muscle—localizing at intercalated discs in heart tissue, Z-bands in cardiomyocytes, and at actin stress fibers, focal adhesions, and cell junctions in other cell types. Its physiological functions include connecting integrins to the actin cytoskeleton, regulating cell adhesion, cytoskeletal organization, and signal transduction by assembling complexes involving the Abelson family of non-receptor tyrosine kinases (Arg/Abl), alpha-actinin, vinculin, flotillin, and other partners. SORBS2 expression is tightly regulated; dysregulation is associated with cardiac pathologies such as hypertrophy and fibrosis, electrical remodeling, and congenital heart defects, and also with muscular dystrophies and cancer cell migration. SORBS2 is not a classical receptor, enzyme, transporter, or ion channel, but rather a scaffolding protein involved in structural and signaling roles within the cell.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorbin and SH3 domain-containing protein 2 (SORBS2).